Short Interest in Adhera Therapeutics, Inc. (OTCMKTS:ATRX) Declines By 58.5%

Adhera Therapeutics, Inc. (OTCMKTS:ATRXGet Rating) was the target of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 8,300 shares, a decrease of 58.5% from the March 31st total of 20,000 shares. Based on an average daily trading volume, of 31,500 shares, the days-to-cover ratio is presently 0.3 days.

Shares of OTCMKTS:ATRX opened at $0.07 on Friday. The business’s 50 day simple moving average is $0.07 and its 200 day simple moving average is $0.11. Adhera Therapeutics has a 1 year low of $0.04 and a 1 year high of $0.48. The company has a market capitalization of $1.12 million, a P/E ratio of -0.11 and a beta of -0.10.

Adhera Therapeutics Company Profile (Get Rating)

Adhera Therapeutics, Inc does not have significant operations. Previously, it was involved in the development and commercialization of drug therapeutics for chronic and acute diseases in the United States. The company was formerly known as Marina Biotech, Inc and changed its name to Adhera Therapeutics, Inc in October 2018.

Read More

Receive News & Ratings for Adhera Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adhera Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.